CD28 and neoplasm: A recent study demonstrated in humanized mouse models that a third-generation construct comparable to our construct, namely CD28/4-1BB CAR T cells targeting CD123, exert no major cytotoxicity against various subsets of normal cells with low CD123 expression, indicating a low on-target/off-tumor toxicity effect48.